456 Studies Now Enrolling
A Placebo-Controlled Study to Evaluate the Effect of a Single Dose of CVN058-103 on Mismatch Negativity in Subjects with Stable Schizophrenia
CVN058 Effect on Mismatch Negativity in Schizophrenics
| Sponsor: | Cerevance |
| Enrolling: | Male and Female Patients |
| IRB Number: | 7677 |
| U.S. Govt. ID: | NCT03669250 |
| Contact: | Marlene Carlson, MPH: 646-774-8436 / mc157@columbia.edu |
Additional Study Information:
The purpose of this study is to determine whether the brain wave patterns are improved after administration of CVN058 compared to placebo in subjects with schizophrenia. The study uses electroencephalography (EEG) to measure naturally occurring brain waves as you listen to recorded sounds.
This study is closed
